S
SYRE
Spyre Therapeutics
74.05
-0.27-0.36%After Hours: 74.05 0.00 0.00%16:10 05/22 EDT
OPEN/PREV CLOSE75.34/74.32
TODAY RANGE73.11-75.63
VOL574.91K
MARKET CAP6.43B
52 WEEK RANGE13.93-78.80
AVG VOL (3M)1.09M
% TURNOVER0.66%
TURNOVER--
P/E (TTM)-29.5774
% RANGE3.39%
EPS(TTM)-2.5036
P/E(FORWARD)-25.4783
P/B8.70
BVPS8.51
DIVIDEND--
P/S1,244.31
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP5.73B
SHARES OUTSTANDING86.84M
NEXT EARNINGS08/03-08/07
FREE FLOAT77.40M
LOT SIZE1
EX-DATE09/08/2023
News
Press Releases
Financial Reports
Profile
Simply Wall St·4d ago
A Look At Spyre Therapeutics (SYRE) Valuation After Wider Losses In Its Latest Quarterly Earnings
Seeking Alpha·05/12 15:01
Healthcare stocks with A+ momentum investors are watching
TipRanks·05/12 14:50
Spyre Therapeutics price target raised to $102 from $86 at Deutsche Bank
Reuters·05/12 07:21
U.S. RESEARCH ROUNDUP-Accuray, Aevex, Zoetis
TipRanks·05/10 01:59
Spyre Therapeutics (SYRE) Receives a Rating Update from a Top Analyst
TipRanks·05/07 11:06
Guggenheim Remains a Buy on Spyre Therapeutics (SYRE)
TipRanks·05/07 08:43
Spyre Therapeutics price target raised to $97 from $64 at Citi
TipRanks·05/07 07:55
Spyre Therapeutics price target raised to $107 from $92 at Stifel
Dow Jones·05/06 19:49
Spyre Therapeutics Is Maintained at Buy by Citigroup
Same Industry
Name/Symbol
Change%
Price